Dr. James T Shirley, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 307 S Washington St, Deridder, LA 70634 Phone: 337-463-3036 |
Dr. Robert B Lestage, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 509 Bon Ami St, Deridder, LA 70634 Phone: 337-463-3272 |
Grace Garbo, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1808 Highway 190 W, Suite D, Deridder, LA 70634 Phone: 337-463-6545 Fax: 337-462-3908 |
Dr. Harry H Goodwin Jr., DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 509 Bon Ami St, Deridder, LA 70634 Phone: 337-463-3272 Fax: 337-463-3288 |
Dr. Leonard H Mcwilliams Jr., DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 501 Bon Ami St, Deridder, LA 70634 Phone: 337-462-1315 Fax: 337-462-6411 |
Dr. Stanley C Maskas, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 602 Bon Ami St, Deridder, LA 70634 Phone: 337-463-7058 Fax: 337-463-0110 |
Dr. Thomas Herbert Shirley, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 307 S Washington St, Deridder, LA 70634 Phone: 337-463-3036 Fax: 337-463-8554 |
News Archive
Monitoring plasma cell-free DNA levels of epidermal growth factor receptor mutations may indicate prognosis for patients with lung adenocarcinoma after EGFR–tyrosine kinase inhibitor therapy, research suggests.
Sycamore Ventures announced today that the company has acquired Trunk Health Products. Trunk Health Products resells and markets health and nutrition products through wholesale and retail outlets.
Vibrational circular dichroism (VCD), a new tool for determining the absolute configuration of chiral molecules, was a key highlight of the recent 24th International Symposium on Chirality, held June 10-13 in Fort Worth, Texas. VCD pioneer, BioTools (Jupiter, FL) was on hand, not only sponsoring the exhibitor's luncheon and the poster awards, but also proudly awarding the Best Poster Given by a Young Scientist for the thirteenth year.
AstraZeneca announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for ticagrelor (BRILINTA™).
› Verified 5 days ago